Steven M. Larson

479 total citations
10 papers, 352 citations indexed

About

Steven M. Larson is a scholar working on Radiology, Nuclear Medicine and Imaging, Neurology and Epidemiology. According to data from OpenAlex, Steven M. Larson has authored 10 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Neurology and 3 papers in Epidemiology. Recurrent topics in Steven M. Larson's work include Neuroblastoma Research and Treatments (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Steven M. Larson is often cited by papers focused on Neuroblastoma Research and Treatments (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Steven M. Larson collaborates with scholars based in United States, Ukraine and Malaysia. Steven M. Larson's co-authors include A R Spitzer, Pim Brouwers, Bijan Safai, Margaret A. Fischl, Samuel Broder, G. R. van den Berg, Alison Wichman, Robert Yarchoan, Arturo Brunetti and Rose V. Thomas and has published in prestigious journals such as The Lancet, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Steven M. Larson

10 papers receiving 337 citations

Peers

Steven M. Larson
M. V. Ragni United States
E A Hische Netherlands
Catherine Seamon United States
Yanhui Cai United States
Kathryn M. Zunich United States
Tetsuya Nakamura Japan
Tosca Kinchelow United States
Karol Serwin Poland
Wyatt J. McDonnell United States
H. Wächter Austria
M. V. Ragni United States
Steven M. Larson
Citations per year, relative to Steven M. Larson Steven M. Larson (= 1×) peers M. V. Ragni

Countries citing papers authored by Steven M. Larson

Since Specialization
Citations

This map shows the geographic impact of Steven M. Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Larson more than expected).

Fields of papers citing papers by Steven M. Larson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Larson. The network helps show where Steven M. Larson may publish in the future.

Co-authorship network of co-authors of Steven M. Larson

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Larson. A scholar is included among the top collaborators of Steven M. Larson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Larson. Steven M. Larson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Souweidane, Mark M., Evan D. Bander, Pat Zanzonico, et al.. (2025). Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma. Neuro-Oncology. 27(8). 2117–2126. 4 indexed citations
2.
Sgouros, George, Joseph A. O’Donoghue, Steven M. Larson, et al.. (1998). Mathematical model of 5-[125I]iodo-2′-deoxyuridine treatment: continuous infusion regimens for hepatic metastases. International Journal of Radiation Oncology*Biology*Physics. 41(5). 1177–1183. 4 indexed citations
3.
Imbriaco, Massimo, Samuel D. J. Yeh, Henry Yeung, et al.. (1997). Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma. Cancer. 80(8). 1507–1512. 31 indexed citations
4.
Cheung, Nai‐Kong V., Samuel D. J. Yeh, Farhad Daghighian, et al.. (1995). Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors. European Journal of Nuclear Medicine and Molecular Imaging. 22(5). 419–426. 15 indexed citations
5.
Uğur, Ömer, Andrew M. Scott, Lale Kostakoğlu, et al.. (1995). Calculated and TLD-based absorbed dose estimates for I-131-labeled 3F8 monoclonal antibody in a human neuroblastoma xenograft nude mouse model. Nuclear Medicine and Biology. 22(1). 87–93. 5 indexed citations
6.
Larson, Steven M., Chaitanya Divgi, Andrew Scott, et al.. (1994). Current status of radioimmunodetection. Nuclear Medicine and Biology. 21(5). 721–729. 1 indexed citations
7.
Bergman, Ira, et al.. (1993). Treatment of spinal epidural neuroblastoma xenografts in rats using anti-GD2 monoclonal antibody 3F8. Journal of Neuro-Oncology. 15(3). 235–242. 5 indexed citations
8.
Mulshine, James L., Anthony M. Treston, Yoichi Nakanishi, et al.. (1989). In vivo diagnosis and therapy of human tumors with monoclonal antibodies: Selection of antibodies and preliminary clinical studies in small cell carcinoma of the lung. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 16(2). 159–162. 2 indexed citations
9.
Schlom, Jeffrey, David Colcher, Mario Roselli, et al.. (1989). Tumor targeting with monoclonal antibody B72.3. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 16(2). 137–142. 24 indexed citations
10.
Yarchoan, Robert, Pim Brouwers, A R Spitzer, et al.. (1987). RESPONSE OF HUMAN-IMMUNODEFICIENCY-VIRUS-ASSOCIATED NEUROLOGICAL DISEASE TO 3'-AZIDO-3'-DEOXYTHYMIDINE. The Lancet. 329(8525). 132–135. 261 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. V. Ragni Breakdown of academic impact, for papers by E A Hische Breakdown of academic impact, for papers by Catherine Seamon Breakdown of academic impact, for papers by Yanhui Cai Breakdown of academic impact, for papers by Kathryn M. Zunich Breakdown of academic impact, for papers by Tetsuya Nakamura Breakdown of academic impact, for papers by Tosca Kinchelow Breakdown of academic impact, for papers by Karol Serwin Breakdown of academic impact, for papers by Wyatt J. McDonnell Breakdown of academic impact, for papers by H. Wächter
Rankless by CCL
2026